Key terms
About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AZN news
Apr 23 11:16am ET AstraZeneca put volume heavy and directionally bearish Apr 23 6:30am ET AstraZeneca reports Voydeya approved in EU as PNH add-on treatment Apr 19 6:21pm ET VGK vs. EZU: Which Is the Better European Stock ETF? Apr 18 9:41am ET Unusually active option classes on open April 18th Apr 16 12:49pm ET AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier) Apr 16 7:12am ET AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC Apr 16 6:20am ET AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial Apr 11 2:27pm ET AstraZeneca’s AGM: Resolutions Passed with Support Apr 11 7:05am ET AstraZeneca announces FDA approval for Fasenra Apr 11 6:14am ET AstraZeneca increases 2024 dividend by 7% to $3.10 per share Apr 09 9:00pm ET ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy? Apr 08 8:41am ET Nuvectis says NXP900 demonstrates robust activity in NSCLC Apr 08 6:58am ET AstraZeneca’s Enhertu Wins US Approval for Tumours Apr 07 6:04am ET ENHERTU approved for treatment of unresectable or metastatic HER2 positive Apr 05 7:03am ET AstraZeneca releases ADRIATIC Phase III trial results on IMFINZI Apr 05 6:57am ET AstraZeneca’s Imfinzi Shows Promise in Lung Cancer Trial Apr 05 5:56am ET AstraZeneca: Imfinzi significantly improved OS and PFS in LS-SCLS in trial Apr 04 12:06pm ET AstraZeneca call volume above normal and directionally bullish Apr 04 4:32am ET AstraZeneca placed on ‘Positive Catalyst Watch’ at JPMorgan Apr 02 1:58pm ET AstraZeneca Reports Voting Rights and Share Capital Apr 02 9:28am ET AstraZeneca’s Voydeya Wins FDA Approval Apr 02 8:28am ET AstraZeneca’s Cancer Drug Closer to FDA Approval Apr 02 7:04am ET AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA accepted in the U.S. Apr 01 7:10am ET AstraZeneca announces FDA approval of Voydeya Apr 01 6:10am ET AstraZeneca shareholders urged to oppose EUR 18.7M pay plan for CEO, FT says Mar 28 2:49pm ET What Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for Investors Mar 27 6:25am ET AstraZeneca, Sanofi announce Beyfortus approved in Japan Mar 27 6:24am ET AstraZeneca’s Truqap with Faslodex approved by Japanese MHLW Mar 26 5:07am ET QQQ ETF Update, 3/26/2024 Mar 25 7:57am ET AstraZeneca’s Ultomiris Revolutionizes NMOSD Treatment Mar 25 7:10am ET FDA approves AstraZeneca’s Ultomiris for rare nerve disease NMOSD
No recent press releases are available for AZN
AZN Financials
Key terms
Ad Feedback
AZN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AZN Competitors
$ Market cap P/E ratio $ Price 1d change 52-week range